Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology
|
|
- Oswin Cunningham
- 5 years ago
- Views:
Transcription
1 Interactive CardioVascular and Thoracic Surgery 20 (2015) doi: /icvts/ivv047 Advance Access publication 11 March 2015 ORIGINAL ARTICLE THORACIC Cite this article as: Nakao M, Hoshi R, Ishikawa Y, Matsuura Y, Uehara H, Mun M et al. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology. Interact CardioVasc Thorac Surg 2015;20: a Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology Masayuki Nakao a, *, Rira Hoshi b, Yuichi Ishikawa c, Yosuke Matsuura a, Hirofumi Uehara a, Mingyon Mun a, Ken Nakagawa a and Sakae Okumura a Department of Thoracic Surgical Oncology, Cancer Institute Hospital, The Japanese Foundation for Cancer Research, Tokyo, Japan b Department of Cytology, Cancer Institute Hospital, The Japanese Foundation for Cancer Research, Tokyo, Japan c Department of Pathology, Cancer Institute Hospital, The Japanese Foundation for Cancer Research, Tokyo, Japan * Corresponding author. Cancer Institute Hospital, Ariake, Koto-ku, Tokyo , Japan. masayuki.nakao@jfcr.or.jp (M. Nakao). Received 30 September 2014; received in revised form 15 January 2015; accepted 23 January 2015 Abstract OBJECTIVES: Positive pleural lavage cytology (PLC) is considered as a precursor condition of pleural dissemination (PD) or malignant pleural effusion (PE), and one of the poor prognostic factors in surgically resected non-small-cell lung cancer (NSCLC) patients. Although PD and PE are classified as M1a, PLC does not contribute to the tumour, node and metastasis (TNM) classification of the Union Internationale Contre le Cancer. This study aimed to evaluate the prognostic effect of positive PLC status in surgically resected NSCLC patients compared with PD and/or PE. We also aimed to consider the contribution of positive PLC status to the TNM classification. METHODS: We reviewed 1572 consecutive patients with completely resected NSCLC, and analysed the relationship between PLC status, other clinicopathological factors and prognosis. The survival rates of 45 patients with PD and/or PE were also investigated. RESULTS: Positive preresection PLC ( pre-plc) status was observed in 56 patients. Pre-PLC status was significantly associated with other clinicopathological factors. Positive pre-plc patients exhibited a worse 5-year overall survival (50.6%) compared with negative pre-plc patients (78.0%), but better survival than PD and/or PE patients (21.0%). Prognosis of positive pre-plc patients was equal to that of pt3, negative pre-plc patients; survival equality was observed when patients were stratified according to pn0, pn1 and pn2. CONCLUSIONS: Positive pre-plc had the significant prognostic effect in surgically resected NSCLC patients. However, it is not a contraindication for surgical resection, unlike PD and/or PE. Our data suggest that positive pre-plc should be classified as pt3 in next TNM classification. Keywords: Lung cancer Surgery Pleural effusion Pleural dissemination INTRODUCTION The first report of pleural lavage cytology (PLC) in non-small-cell lung cancer (NSCLC) was published by Spjut et al. [1] in Since then, although there have been some differences regarding the sampling and specimen handling methods used, many studies have suggested that PLC status is a significant prognostic factor in surgically resected NSCLC patients [2 13]. We previously assessed the prognostic effect of positive PLC status, which focused on recurrence patterns in early-stage disease in 2007 [2]. The presence of cancer cells in pleural lavage indicates the spread of microscopic intrapleural cancer resulting from visceral pleural invasion, vascular invasion or lymphatic permeation of the primary lesion. It is considered to be the precursor of pleural dissemination (PD) or malignant pleural effusion (PE). PD and PE are classified as M1a in the tumour, node and metastasis (TNM) classification of the Union Internationale Contre le Cancer (UICC) because of their strong effect on patient survival [14 16]. They are grouped in stage IV, and are considered to be contraindications for surgical resection. However, PLC status does not contribute to the TNM classification, and the appropriate management of positive PLC patients is controversial. This study aimed to evaluate the prognostic effect of positive PLC in surgically resected NSCLC patients compared with PD and/ or PE. We also aimed to consider the contribution of positive PLC status to the TNM classification. PATIENTS AND METHODS Patients A total of 1572 consecutive NSCLC patients were enrolled in this retrospective study. They underwent complete surgical resection ORIGINAL ARTICLE The Author Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
2 778 M. Nakao et al. / Interactive CardioVascular and Thoracic Surgery at our institution without any preoperative anticancer treatment between January 1991 and December Complete resection was defined as either lobectomy or more extensive resection with systematic ipsilateral hilar and mediastinal lymph node dissection through thoracotomy or thoracoscopic procedure, and an absence of residual cancer both macroscopically and histologically. In addition, 45 NSCLC patients with PD and/or PE were also investigated to compare the survival probability rates. A total of 23 patients of clinical (c) Stage I, 8 patients of cstage II and 11 patients of cstage III were included. Because PD and PE were found unexpectedly during an operation and the disseminated nodules were localized, patients underwent lobectomy or more extensive resection and resection of disseminated nodules for macroscopically complete resection during the same period. Three patients of cstage IV also underwent macroscopically complete resection. Patients who underwent exploratory thoracotomy or only partial resection of the main lesions were excluded. Adjuvant chemotherapy was performed, according to patient s general condition and will, in a part of patients with stage II III disease using platinum-based doublet regimens and a part of patients with stage IB disease using oral UFT. All patients were followed up on an outpatient basis at a minimum of every 6 months by physical check-up, chest computed tomography and laboratory testing and every 12 months by systemic examination until 5 years after surgery. We reviewed the medical records of all patients for the following clinicopathological factors: age, gender, cstage, pathological T and N (pt and pn) classification, histological type, pleural invasion, PLC status and adjuvant chemotherapy. Histopathological evaluation Histological classification of the resected specimens was determined according to the World Health Organization International Histological Classification of Tumors [17]. Clinical and pathological stage was determined according to the UICC TNM Classification for Lung and Pleural Tumors [14, 15]. Pleural invasion was defined by detailed evaluation of sliced specimens stained using the Elastica van Gieson method, and was classified as follows: Pl0, tumour within the subpleural lung parenchyma or superficial invasion into the pleural connective tissue beneath the elastic layer; Pl1, tumour invasion beyond the elastic layer; Pl2, tumour invasion to the pleural surface; and Pl3, tumour invasion to any part of the parietal pleura. Lymphatic permeation and vascular invasion were excluded from the analysis because of a lack of data in many patients. Pleural lavage cytology Immediately after thoracotomy, the pleural cavity was washed with 100 ml of physiological saline solution before any surgical manipulation. The surgeon avoided touching the pleural surface to obtain only desquamated cells. The fluid was carefully removed, and then centrifuged at 1500 rpm for 5 min. The resulting sedimented material was stained using the Papanicolaou method, and the results of the cytological examination were divided into three categories: negative, suggestive and positive. Only samples with positive findings were defined as positive preresection PLC ( pre-plc). In cases with pleural adhesions, they were performed after removing adhesions by necessity. After tumour resection and systematic lymph node dissection, the pleural cavity was washed with ml of physiological saline solution before wound closure. Fifty millilitres of the saline wash solution was removed, and evaluated in the same manner for pre-plc. Only samples with positive findings were defined as positive post-resection PLC (post-plc) [2]. Statistical analysis The Fisher s exact test was used to analyse the correlation between PLC status and other clinicopathological factors. Cox proportional hazard regression model was used to identify statistically significant differences in survival and to estimate hazard ratios and 95% confidence intervals. Survival curves were plotted using the Kaplan Meier method, and the statistical significance of differences among subgroups was determined using the log-rank test. The end-point for analyses was overall survival, which was measured from the date of surgery to the date of death by any cause. The last follow-up observation was censored when the patient was alive or lost to the follow-up. Cancer recurrence was divided into three categories according to the site of initial recurrence: locoregional, pleural and distant. Locoregional recurrence was defined as disease in the ipsilateral lung, and hilar and mediastinal lymph nodes. Pleural recurrence was defined as disease within the hemithoracic pleura, and distant recurrence was defined as any other disease. All P-values were two-sided, and P < 0.05 were considered to indicate a statistically significant difference. We used the statistical analysis software (Dr SPSS II for Windows, Standard Version 11.0, SPSS, Inc., Chicago, IL, USA) for all analyses. Clinicopathological and survival data were collected based on a retrospective chart review and no personally identifiable information was included. Data collection and analysis were approved and the need for obtaining informed consent from each patient was waived by the Institutional Review Board. RESULTS Positive prepleural lavage cytology and clinicopathological features The clinicopathological characteristics of the 1572 NSCLC patients are given in Table 1. The pre-plc status was assessed in all 1572 patients, and a positive result was observed in 56 (3.6%). The post-plc status was assessed in 1135 patients because it was not a mandatory procedure in early phase of the study period, and a positive result was observed in only three patients. Because of the lack of data from many cases and the small number of positive patients, post-plc status was excluded from subsequent analyses. The correlations between pre-plc status and other clinicopathological factors are given in Table 2. Positive pre-plc was significantly correlated with a higher pt (P < 0.001) and pn (P < 0.001) classification, as well as the presence of pleural invasion (P < 0.001). Although adenocarcinoma was the major histology of positive pre-plc patients, the same trend was also observed in negative pre-plc patients. Effect of prepleural lavage cytology on survival The median length of the overall follow-up for the censored patients was 5.6 years. The correlations between pre-plc status and disease recurrence are given in Table 3. Recurrence was
3 M. Nakao et al. / Interactive CardioVascular and Thoracic Surgery 779 Table 1: Clinicopathological characteristics of the patients Table 2: Correlations between pre-plc status and other clinicopathological factors Patients (N = 1572) n % Age (years) Median (range) 65 (16 86) Sex Male Female cstage I II III pstage I II III Histological type Adenocarcinoma Squamous cell ca Adenosquamous ca LCNEC Large cell ca Others Pleural invasion pl pl pl pl Pre-PLC Positive Negative Post-PLC a Positive Negative Adjuvant Yes chemotherapy No a Data not available for 437 patients. LCNEC: large cell neuroendocrine carcinoma; PLC: pleural lavage cytology. observed more frequently (P < 0.001) and the rate of pleural recurrence at the initial site was higher (P < 0.001) in pre-plc-positive patients. There were no significant differences in the sites of recurrence other than pleural recurrence between groups (P = 0.133). The prognostic significance of positive pre-plc status and other clinicopathological features for overall survival is presented in Table 4. Univariate analysis revealed that patient survival was significantly associated with pre-plc status, as well as age, gender, pt classification, pn classification, histological type and pleural invasion. The positive pre-plc group had a relatively worse 5-year overall survival rate (50.6%) than the negative pre-plc group (78.0%). Multivariate analysis was performed among pre-plc status and other three factors; pt classification, pn classification and pleural invasion. They were the prognostic factors investigated in univariate analyses, and had close correlation with pre-plc status. The result showed that pre-plc status was not an independent predictor of poor outcome (P = 0.289). Pre-PLC Negative (N = 1516) Positive (N = 56) P-values Age Sex Female Male cstage I II III pt classification T T T T4 8 0 <0.001 pn classification N N N <0.001 Histological type Adenocarcinoma Others Pleural invasion pl pl pl pl <0.001 Adjuvant chemotherapy Yes No PLC: pleural lavage cytology. Table 3: Correlations between pre-plc status and initial recurrent sites Pre-PLC Negative (N = 1516) Positive (N = 56) P-values Recurrent cases <0.001 Pleural recurrence <0.001 Other sites recurrence a Locoregional recurrence 67 2 Distant recurrence ORIGINAL ARTICLE a Data not available for 10 patients. Positive prepleural lavage cytology and pleural dissemination or malignant pleural effusion survival Survival curves of the positive and negative pre-plc groups are shown in Fig. 1. To compare the survival probability rates, the survival curve of 45 patients with PD and/or PE was interposed. The positive pre-plc group exhibited better 5-year overall survival rate compared with the PD and/or PE group (50.6 vs 20.9%, P = 0.006). Incorporating pre pleural lavage cytology into tumour, node and metastasis classification Figure 2 shows the survival curves of positive pre-plc patients according to their pt classification. Because of the small number of patients, pt1 patients were assessed together with pt2. The 5-year overall survival rates were 59.4% for 39 patients with pt1 2, compared with 31.9% in 17 patients with pt3 tumours. Because
4 780 M. Nakao et al. / Interactive CardioVascular and Thoracic Surgery Table 4: Prognostic significance of pre-plc status and other clinicopathological factors for overall survival Number Univariate analysis Multivariate analysis 5-ys (%) P-values HR 95% CI P-values Age (years) <0.001 Sex Female Male <0.001 pt classification T T < <0.001 pn classification N N < <0.001 Histological type Adenocarcinoma Others < Pleural invasion pl pl < Pre-PLC Negative Positive < Adjuvant chemotherapy Yes No ys: 5-year overall survival rate; PLC: pleural lavage cytology; HR: hazard ratio; CI: confidence interval. Figure 1: Overall survival curves of the positive pre-plc, negative pre-plc and PD/PE groups. PLC: pleural lavage cytology; PD: pleural dissemination; PE: malignant pleural effusion. there were no statistically significant differences in survival between the two groups of positive pre-plc patients (P = 0.082), we considered they could be grouped in the same pt classification. Figure 3 shows a comparison of the survival curves of positive and negative pre-plc patients stratified by pt classification. The 5-year overall survival rates of the negative pre-plc patients were 88.9% in pt1, 73.9% in pt2 and 54.3% in pt3. The prognoses of the three groups of negative pre-plc patients were significantly different (pt1 vs pt2, P < 0.001; pt2 vs pt3, P < 0.001; pt1 vs pt3, P < 0.001). The overall survival rate of the positive pre-plc group was equal to that of pt3 negative pre-plc patients (P = 0.583). The results of the same comparisons stratified according to pn classification are shown in Fig. 4. The overall survival rates of positive pre-plc patients were also equal to those of pt3 negative Figure 2: Overall survival curves of positive pre-plc patients according to pt classification (pt1-2 vs pt3). pre-plc patients in pn0 (P = 0.596), pn1 (P = 0.774) and pn2 (P = 0.459) status. DISCUSSION There have been many previous studies that have suggested poor outcome of positive PLC NSCLC patients. The incidence of positive pre-plc findings ranged % in previous reports, with most studies reporting an incidence of 5% [2 13]. The pre-plc status was found to be positive in 3.6% of cases in the present study, which is reasonable. Although the study period was long, difference in the incidence of a positive finding between periods was within the acceptable range, 4.4% from 1991 to 2002 and
5 M. Nakao et al. / Interactive CardioVascular and Thoracic Surgery 781 Figure 3: Overall survival curves of positive and negative pre-plc patients stratified by pt classification. Figure 4: Stratified analysis of comparisons between the positive pre-plc group and pt3 negative pre-plc patients in pn0, pn1 and pn2 status. 2.8% from 2003 to Some previous studies also suggested that positive post-plc findings have prognostic importance, with an incidence of % [7, 8]. However, positive post-plc status was extremely rare in the current study, and was detected in only three patients. This may be because of the manner in which we assessed post-plc status. We sampled 50 ml of the ml physiological saline solution used to wash the pleural cavity. In some positive pre-plc cases, we also infused hypotonic cisplatin or distilled water into the pleural cavity as adjuvant therapies. Although this did not contribute to overall survival as we reported previously [2], it may have affected the low frequency of positive post-plc cases. In the present study, we aimed to clarify the prognostic differences between positive pre-plc and PD and/or PE status. Although a positive PLC status is considered to be a precursor condition for PD and/or PE, the differences between these conditions have not been assessed in detail, previously [7, 10]. We enrolled 45 surgically resected patients with PD and/or PE during the same period, excluding individuals who underwent exploratory thoracotomy or only partial resection of the main lesions. Although they did not undergo histological complete resection, they were the most appropriate group to compare the survival probability with the positive PLC group because almost the same operative procedure was performed. Our results suggested that positive pre-plc patients had a much better 5-year overall survival (50.6%) than the PD and/or PE group (21.0%). These findings suggest that a positive PLC status is not equal to PD and/or PE; thus, it is not a contraindication for surgical resection. We performed exploratory analysis to incorporate pre-plc status into the TNM classification. Our results suggested that a positive pre-plc status was a significant prognostic factor in univariate analysis, but was not an independent predictor of poor outcome in multivariate analysis. We speculate that a positive pre-plc status is closely correlated with other clinicopathological factors and should be incorporated into one of the existing TNM factors. Because there were no significant differences in survival between the pt1 2 and pt3 groups in positive pre-plc patients, we considered they could be grouped in the same pt classification. We propose that positive pre-plc status should be classified as pt3 on the basis of survival equality. Although a small number of cases were included in each group, our proposal was verified by additional analyses according to pn status. Lim et al. [9] suggested that it be appropriate to upstage patients with a positive pre-plc status by one T classification. Their recommendation is consistent with the current proposal, whereby pre-plc status should be incorporated into the T factor. Although their study included a large number of patients from multiple institutions and had strong statistical power, there is a matter of data accuracy. Because there are no established methods to sample PLC and handle the specimens or diagnostic criteria, the incidence of positive PLC results varies among institutions. Although the current study scale is smaller, it has the benefit of including high-quality data from a unified procedure performed at a single institution. Kaneda et al. [4] suggested that a precise diagnosis of positive pre-plc status as PL3 (=T3) was appropriate. They performed a survival comparison between positive pre-plc patients and each of the PL0 3 groups. Although the assessment process differed, their results were consistent with those of the current study. Although the results of previous reports have slightly varied in terms of frequency and prognosis, data consistently revealed that positive pre-plc patients have a worse prognosis than negative pre-plc patients. However, the treatment of these patients in ORIGINAL ARTICLE
6 782 M. Nakao et al. / Interactive CardioVascular and Thoracic Surgery clinical practice remains unclear. Our results revealed a prognostic difference between positive pre-plc and PD and/or PE patients. Surgical resection may contribute greatly to improve their prognosis. Because the pre-plc status can be obtained at thoracotomy, neoadjuvant therapies may be difficult to indicate. Curative surgery and systemic adjuvant treatments would be the only ways to improve patient prognosis. It is important to establish a routine PLC sampling method and unified diagnostic criteria to allow the accumulation of precise data regarding positive pre-plc patients and accurately assess the contribution of a positive PLC status to the TNM classification. A large amount of data that are prospectively collected following these methods and criteria will clarify the features and prognosis of patients with a positive PLC status. CONCLUSIONS A positive pre-plc status had a significant prognostic effect in surgically resected NSCLC patients. However, positive pre-plc patients had a much better 5-year overall survival rate compared with those with surgically resected PD and/or PE. Therefore, positive PLC is a precursor but not equal to PD and/or PE, and surgical resection may help improve patient prognosis. We propose that positive pre-plc status should be classified as pt3 in the next TNM classification. Conflict of interest: none declared. REFERENCES [1] Spjut HJ, Hendrix VJ, Ramirez GA, Roper CL. Carcinoma cells in pleural cavity washings. Cancer 1958;11: [2] Satoh Y, Hoshi R, Ishikawa Y, Horai T, Okumura S, Nakagawa K. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology. Ann Thorac Surg 2007;83: [3] Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Takenaka A et al. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up. Eur J Cardiothorac Surg 2009;35: [4] Kaneda M, Yokoi K, Ito S, Niwa H, Takao M, Kondo R et al. The value of pleural lavage cytology examined during surgery for primary lung cancer. Eur J Cardiothorac Surg 2012;41: [5] Kawachi R, Nakazato Y, Masui K, Takei H, Koshi-ishi Y, Goya T. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology? Interact CardioVasc Thorac Surg 2009;9: [6] Taniguchi Y, Nakamura H, Miwa K, Adachi Y, Fujioka S, Haruki T et al. Prognostic significance of pleural lavage cytology after thoracotomy and before closure of the chest in lung cancer. Interact CardioVasc Thorac Surg 2009;9: [7] Aokage K, Yoshida J, Ishii G, Enatsu S, Hishida T, Nishimura M et al. The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer. J Thorac Cardiovasc Surg 2010; 139: e1241. [8] Kotoulas C, Lazopoulos G, Karaiskos T, Tomos P, Konstantinou M, Papamichalis G et al. Prognostic significance of pleural lavage cytology after resection for non-small cell lung cancer. Eur J Cardiothorac Surg 2001;20: [9] Lim E, Clough R, Goldstraw P, Edmonds L, Aokage K, Yoshida J et al. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: an international individual patient data meta-analysis. J Thorac Cardiovasc Surgery 2010; 139: [10] Okada M, Sakamoto T, Nishio W, Uchino K, Tsuboshima K, Tsubota N. Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections. J Thorac Cardiovasc Surg 2003;126: [11] Shintani Y, Ohta M, Iwasaki T, Ikeda N, Kanou T, Tomita E et al. Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer. J Thorac Cardiovasc Surg 2009;137: [12] Li YN, Shi HZ, Liang QL, Yang HB, Huang GM. Prognostic significance of pleural lavage cytology in patients with lung cancer: a meta-analysis. Lung Cancer (Amsterdam, Netherlands) 2008;60: [13] Saso S, Rao C, Ashrafian H, Ghaem-Maghami S, Darzi A, Athanasiou T. Positive pre-resection pleural lavage cytology is associated with increased risk of lung cancer recurrence in patients undergoing surgical resection: a meta-analysis of 4450 patients. Thorax 2012;67: [14] Goldstraw P. Staging Manual in Thoracic Oncology. Denver, CO: IASLC, 2009, [15] International Union against Cancer. In: Sobin LH, Wittekind CH (eds). TNM Classification of Malignant Tumours, 7th edn. New York, NY: Wiley-Liss, 2009, [16] Postmus PE, Brambilla E, Chansky K, Crowley J, Goldstraw P, Patz EF Jr et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007;2: [17] Travis WD, Brambilla E, Muller-Hermelink HK. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IASLC Press, 2004,
Pleural lavage cytology as an independent prognostic factor in non-small cell lung cancer patients with stage I disease and adenocarcinoma
244 Pleural lavage cytology as an independent prognostic factor in non-small cell lung cancer patients with stage I disease and adenocarcinoma DAISUKE HOKKA 1, KAZUYA UCHINO 2, KENTA TANE 2, HIROYUKI OGAWA
More informationIntraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer
Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer Yasushi Shintani, MD, hd, a Mitsunori Ohta, MD, hd, a Teruo Iwasaki, MD, hd, a Naoki
More informationPulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy
European Journal of Cardio-Thoracic Surgery 41 (2012) 25 30 doi:10.1016/j.ejcts.2011.04.010 ORIGINAL ARTICLE Pulmonary resection for lung cancer with malignant pleural disease first detected at thoracotomy
More informationIn the mid 1970s, visceral pleural invasion (VPI) was included
ORIGINAL ARTICLE Tumor Invasion of Extralobar Soft Tissue Beyond the Hilar Region Does Not Affect the Prognosis of Surgically Resected Lung Cancer Patients Hajime Otsuka, MD,* Genichiro Ishii, MD, PhD,*
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationExtent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer
Thoracic Cancer ISSN 1759-7706 ORIGINAL ARTICLE Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer Yangki Seok 1, Ji Yun Jeong 2 & Eungbae
More informationIn 1989, Deslauriers et al. 1 described intrapulmonary metastasis
ORIGINAL ARTICLE Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD,* Yasunori Sohara, MD, Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, and Etsuo Miyaoka,
More informationPrognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution
Maruyama et al General Thoracic Surgery Prognostic value of visceral pleural invasion in resected non small cell lung cancer diagnosed by using a jet stream of saline solution Riichiroh Maruyama, MD Fumihiro
More informationVisceral pleura invasion (VPI) was adopted as a specific
ORIGINAL ARTICLE Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database Junji Yoshida,
More informationVisceral pleural involvement (VPI) of lung cancer has
Visceral Pleural Involvement in Nonsmall Cell Lung Cancer: Prognostic Significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu, MD, PhD, Sosuke Yamada, MD, and Kosei Yasumoto,
More informationSrdjan Saso, 1 Christopher Rao, 2 Hutan Ashrafian, 2 Sadaf Ghaem-Maghami, 1 Ara Darzi, 2 Thanos Athanasiou 2 ORIGINAL ARTICLE.
< Additional appendices are published online only. To view these files please visit the journal online (http://thorax.bmj. com/content/67/6.toc). 1 Division of Surgery and Cancer, Institute of Reproductive
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationVisceral pleural invasion (VPI) of lung cancer has been
ORIGINAL ARTICLE Visceral Pleural Invasion Classification in Non Small- Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer: Validation Analysis Based on a
More informationLong-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer
ORIGINAL ARTICLE Long-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer Ryo Maeda, MD,* Junji Yoshida, MD,* Genichiro Ishii, MD, Keiju Aokage, MD,*
More informationEvaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution
Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution Kotaro Kameyama, MD, a Mamoru Takahashi, MD, a Keiji Ohata, MD, a
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More informationPrognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients
1 Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan 2 Department of Pathology, Research Center for Innovative Oncology, National Cancer Center Hospital East,
More informationValidation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer
Original Article Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer Hee Suk Jung 1, Jin Gu Lee 2, Chang Young Lee 2, Dae Joon Kim 2, Kyung Young Chung 2 1 Department
More informationPrognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China
www.springerlink.com Chin J Cancer Res 23(4):265 270, 2011 265 Original Article Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai,
More informationPrognostic value of visceral pleura invasion in non-small cell lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 865 869 www.elsevier.com/locate/ejcts Prognostic value of visceral pleura invasion in non-small cell lung cancer q Jeong-Han Kang, Kil Dong Kim, Kyung
More informationORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery
Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationThe accurate assessment of lymph node involvement is
ORIGINAL ARTICLE Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? Shenhai Wei, MD, PhD,*
More informationAlthough ipsilateral intrapulmonary metastasis (PM), Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis
Evaluation of TMN Classification for Lung Carcinoma With Ipsilateral Intrapulmonary Metastasis Morihito Okada, MD, Noriaki Tsubota, MD, Masahiro Yoshimura, MD, Yoshifumi Miyamoto, MD, and Reiko Nakai,
More informationLung cancer is the most common cause of cancer-related
Original Article Prognostic Factors Based on Clinicopathological Data Among the Patients with Resected Peripheral Squamous Cell Carcinomas of the Lung Tomonari Kinoshita, MD,* Takashi Ohtsuka, MD, PhD,*
More informationNode-Negative Non-small Cell Lung Cancer
ORIGINAL ARTICLE Node-Negative Non-small Cell Lung Cancer Pathological Staging and Survival in 1765 Consecutive Cases Benjamin M. Robinson, BSc, MBBS, Catherine Kennedy, RMRA, Jocelyn McLean, RN, MN, and
More informationTherapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer
Original Article Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer Hiroaki Kuroda 1,2, Yukinori Sakao 1,2, Mingyon Mun 2, Noriko Motoi 3, Yuichi Ishikawa 3, Ken
More informationLung cancer is now a major cause of death in developed
Original Article New IASLC/ATS/ERS Classification and Invasive Tumor Size are Predictive of Disease Recurrence in Stage I Lung Adenocarcinoma Naoki Yanagawa, MD, PhD,* Satoshi Shiono, MD, PhD, Masami Abiko,
More informationVisceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size
GENERAL THORACIC Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD, Neda Kalhor, MD, Wayne L. Hofstetter,
More informationLung cancer is one of the leading causes of death in most
ORIGINAL ARTICLE Japanese Lung Cancer Registry Study of 11,663 Surgical Cases in Demographic and Prognosis Changes Over Decade Noriyoshi Sawabata, MD, PhD,* Etsuo Miyaoka, PhD, Hisao Asamura, MD, PhD,
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationLong-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules
Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA
More informationXiang Hu*, Liang Cao*, Yi Yu. Introduction
Original Article Prognostic prediction in gastric cancer patients without serosal invasion: comparative study between UICC 7 th edition and JCGS 13 th edition N-classification systems Xiang Hu*, Liang
More informationStandard treatment for pulmonary metastasis of non-small
ORIGINAL ARTICLE Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer Kenichi Okubo, MD,* Toru Bando, MD,* Ryo Miyahara, MD,* Hiroaki Sakai, MD,* Tsuyoshi Shoji, MD,* Makoto Sonobe, MD,* Takuji
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationPrognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis
< A supplementary figure and table are published online only at http://thx.bmj.com/content/ vol65/issue3. 1 Institute of Clinical Medicine, National Yang-Ming University, 2 Department of Surgery, Cathay
More informationSublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko Higashiyama, MD, PhD, Tomio Nakayama, MD, PhD,
More informationSurgical resection is the first treatment of choice for
Predictors of Lymph Node and Intrapulmonary Metastasis in Clinical Stage IA Non Small Cell Lung Carcinoma Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, and Yutaka Nishiwaki,
More informationLymph node dissection for lung cancer is both an old
LOBE-SPECIFIC EXTENT OF SYSTEMATIC LYMPH NODE DISSECTION FOR NON SMALL CELL LUNG CARCINOMAS ACCORDING TO A RETROSPECTIVE STUDY OF METASTASIS AND PROGNOSIS Hisao Asamura, MD Haruhiko Nakayama, MD Haruhiko
More informationPrognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer
Ann Thorac Cardiovasc Surg 2011; 17: 58 62 Case Report Prognostic Factors of Pathologic Stage IB Non-small Cell Lung Cancer Motoki Yano, MD, Hidefumi Sasaki, MD, Satoru Moriyama, MD, Osamu Kawano MD, Yu
More informationPoor Prognostic Factors in Patients With Stage IB Non-small Cell Lung Cancer According to the Seventh Edition TNM Classification
CHEST Original Research Poor Prognostic Factors in Patients With Stage IB Non-small Cell Lung Cancer According to the Seventh Edition TNM Classification LUNG CANCER Ryo Maeda, MD ; Junji Yoshida, MD, PhD
More informationThe prognostic significance of central fibrosis of adenocarcinoma
Prognostic Significance of the Size of Central Fibrosis in Peripheral Adenocarcinoma of the Lung Kenji Suzuki, MD, Tomoyuki Yokose, MD, Junji Yoshida, MD, Mitsuyo Nishimura, MD, Kenro Takahashi, MD, Kanji
More informationLung cancer is the leading cause of cancer deaths worldwide.
ORIGINAL ARTICLE Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non Small-Cell Lung Cancer Jung-Jyh Hung, MD, PhD,* Wen-Juei Jeng, MD, Wen-Hu
More informationPrognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer
CHEST Original Research Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer Jung-Jyh Hung, MD, PhD ; Wen-Juei Jeng, MD ; Wen-Hu
More informationInvasion to the visceral pleura is an important component
Diagnosis of Visceral Pleural Invasion by Lung Cancer Using Intraoperative Touch Cytology Yushi Saito, MD, PhD, Yosuke Yamakawa, MD, PhD, Masanobu Kiriyama, MD, PhD, Ichiro Fukai, MD, PhD, Satoshi Kondo,
More informationPrognostic factors in curatively resected pathological stage I lung adenocarcinoma
Original Article Prognostic factors in curatively resected pathological stage I lung adenocarcinoma Yikun Yang 1, Yousheng Mao 1, Lin Yang 2, Jie He 1, Shugeng Gao 1, Juwei Mu 1, Qi Xue 1, Dali Wang 1,
More informationPeritoneal Involvement in Stage II Colon Cancer
Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.
More informationApplicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers
European Journal of Cardio-thoracic Surgery 36 (2009) 1031 1036 www.elsevier.com/locate/ejcts Applicability of the revised International Association for the Study of Lung Cancer staging system to operable
More informationImpact of Large Tumor Size on Survival After Resection of Pathologically Node Negative (pn0) Non Small Cell Lung Cancer
Impact of Large Tumor Size on Survival After Resection of Pathologically Node Negative (pn0) Non Small Cell Lung Cancer Shin-ichi Takeda, MD, Shimao Fukai, MD, Hikotaro Komatsu, MD, Etsuo Nemoto, MD, Kenji
More informationTHE PROGNOSTIC SIGNIFICANCE OF TUMOR CELL DETECTION IN INTRAOPERATIVE PLEURAL LAVAGE AND LUNG TISSUE CULTURES FOR PATIENTS WITH LUNG CANCER
THE PROGNOSTIC SIGNIFICANCE OF TUMOR CELL DETECTION IN INTRAOPERATIVE PLEURAL LAVAGE AND LUNG TISSUE CULTURES FOR PATIENTS WITH LUNG CANCER J. Buhr, MD a K. H. Berghfiuser, MD b S. Gonner, MD b C. Kelm,
More informationAccepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD
Accepted Manuscript Risk stratification for distant recurrence of resected early stage NSCLC is under construction Michael Lanuti, MD PII: S0022-5223(17)32392-9 DOI: 10.1016/j.jtcvs.2017.10.063 Reference:
More informationPrognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma
Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma Masaki Tomita, MD, PhD, Tetsuya Shimizu, MD, PhD, Yasunori Matsuzaki, MD, PhD, Masaki
More informationSegmentectomy for selected ct1n0m0 non small cell lung cancer: A prospective study at a single institute
Segmentectomy for selected ct1n0m0 non small cell lung cancer: A prospective study at a single institute Hiroaki Nomori, PhD, a Takeshi Mori, PhD, b Koei Ikeda, PhD, b Kentaro Yoshimoto, PhD, b Kenichi
More informationPrognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule
Original Article Prognostic prediction of clinical stage IA lung cancer presenting as a pure solid nodule Jong Hui Suh 1, Jae Kil Park 2, Youngkyu Moon 2 1 Department of Thoracic & Cardiovascular Surgery,
More informationLung cancer involving neighboring structures is classified
GENERAL THORACIC Subcategorization of Resectable Non-Small Cell Lung Cancer Involving Neighboring Structures Noriaki Sakakura, MD, Shoichi Mori, MD, Futoshi Ishiguro, MD, Takayuki Fukui, MD, Shunzo Hatooka,
More informationA comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer
European Journal of Cardio-Thoracic Surgery 49 (2016) 580 588 doi:10.1093/ejcts/ezv134 Advance Access publication 18 April 2015 ORIGINAL ARTICLE Cite this article as: Lee GD, Kim DK, Moon DH, Joo S, Hwang
More informationThe T4 category of lung cancer is defined by invasion of the
Original Article Results of T4 Surgical Cases in the Japanese Lung Cancer Registry Study Should Mediastinal Fat Tissue Invasion Really be Included in the T4 Category? Shun-ichi Watanabe, MD,* Hisao Asamura,
More informationThe tumor, node, metastasis (TNM) staging system of lung
ORIGINAL ARTICLE Peripheral Direct Adjacent Lobe Invasion Non-small Cell Lung Cancer Has a Similar Survival to That of Parietal Pleural Invasion T3 Disease Hao-Xian Yang, MD, PhD,* Xue Hou, MD, Peng Lin,
More informationRisk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non small cell lung cancer
Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non small cell lung cancer Terumoto Koike, MD, PhD, a,b Teruaki Koike, MD, PhD, a Katsuo Yoshiya,
More informationRESEARCH ARTICLE. Masaki Tomita 1, Takanori Ayabe 1, Eiichi Chosa 1, Naohiro Nose 1, Kunihide Nakamura 2 * Abstract. Introduction
RESEARCH ARTICLE Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer Masaki Tomita 1, Takanori
More informationThe 7th Edition of TNM in Lung Cancer.
10th European Conference Perspectives in Lung Cancer. Brussels, March 2009. The 7th Edition of TNM in Lung Cancer. Peter Goldstraw, Consultant Thoracic Surgeon, Royal Brompton Hospital, Professor of Thoracic
More informationThe Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer
Original Article The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non Small-Cell Lung Cancer Chen Qiu, MD,* Wei Dong, MD,* Benhua Su, MBBS, Qi Liu, MD,* and Jiajun Du, PhD Introduction:
More informationA new scoring system for peritoneal metastasis in gastric cancer
Gastric Cancer (2003) 6: 146 152 DOI 10.1007/s10120-003-0243-6 2003 by International and Japanese Gastric Cancer Associations Original article A new scoring system for peritoneal metastasis in gastric
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationPulmonary Metastasectomy for Pulmonary Metastases of Head and Neck Squamous Cell Carcinomas
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationA Proposed Strategy for Treatment of Superficial Carcinoma. in the Thoracic Esophagus Based on an Analysis. of Lymph Node Metastasis
Kitakanto Med J 2002 ; 52 : 189-193 189 A Proposed Strategy for Treatment of Superficial Carcinoma in the Thoracic Esophagus Based on an Analysis of Lymph Node Metastasis Susumu Kawate,' Susumu Ohwada,'
More informationClinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer
Original Article Clinical significance of skipping mediastinal lymph node metastasis in N2 non-small cell lung cancer Jun Zhao*, Jiagen Li*, Ning Li, Shugeng Gao Department of Thoracic Surgery, National
More informationSelective lymph node dissection in early-stage non-small cell lung cancer
Review Article Selective lymph node dissection in early-stage non-small cell lung cancer Han Han 1,2, Haiquan Chen 1,2 1 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai
More informationPrognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer
Yonago Acta Medica 2017;60:213 219 doi: 10.24563/yam.2017.12.001 Original Article Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer Yasuaki Kubouchi,
More informationStage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis
Original Article Stage I synchronous multiple primary non-small cell lung cancer: CT findings and the effect of TNM staging with the 7th and 8th editions on prognosis Jingxu Li, Xinguan Yang, Tingting
More informationClinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication for Repeat Metastasectomy
Respiratory Medicine Volume 2015, Article ID 570314, 5 pages http://dx.doi.org/10.1155/2015/570314 Clinical Study Metastasectomy of Pulmonary Metastases from Osteosarcoma: Prognostic Factors and Indication
More informationResearch Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically Resected Lung Adenocarcinoma
BioMed Research International, Article ID 64568, 6 pages http://dx.doi.org/.55/24/64568 Research Article Prognostic Implication of Predominant Histologic Subtypes of Lymph Node Metastases in Surgically
More informationDiagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells in lung-cancer-associated pleural effusion
Received: 1 May 2016 Revised: 19 June 2016 Accepted: 10 July 2016 DOI: 10.1111/crj.12527 ORIGINAL ARTICLE Diagnostic and prognostic significance of receptor-binding cancer antigen expressed on SiSo cells
More informationRevisiting Stage IIIB and IV Non-small Cell Lung Cancer. Analysis of the Surveillance, Epidemiology, and End Results Data
CHEST Revisiting Stage IIIB and IV Non-small Cell Lung Cancer Analysis of the Surveillance, Epidemiology, and End Results Data William N. William, Jr, MD; Heather Y. Lin, PhD; J. Jack Lee, PhD; Scott M.
More informationSince the introduction of low-dose helical computed tomography
Original Article Prognostic Impact of Tumor Size Eliminating the Ground Glass Opacity Component Modified Clinical T Descriptors of the Tumor, Node, Metastasis Classification of Lung Cancer Shota Nakamura,
More informationLocoregional treatment Session Oral Abstract Presentation Saulo Brito Silva
Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationRatio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Original Article Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer Fangfang Chen 1 *, Yanwen Yao 2 *, Chunyan
More informationIn non small cell lung cancer, metastasis to lymph nodes, the N factor, is
Okada et al General Thoracic Surgery Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors Morihito Okada, MD, PhD Toshihiko Sakamoto, MD,
More informationEsophageal cancer is a significant health hazard for
Postoperative Radiotherapy Improved Survival of Poor Prognostic Squamous Cell Carcinoma Esophagus GENERAL THORACIC Junqiang Chen, MD, Ji Zhu, MD, Jianji Pan, MD, Kunshou Zhu, MD, Xiongwei Zheng, MD, Mingqiang
More informationClinical Usefulness of the WHO Histological Classification of Thymoma
Original Article Clinical Usefulness of the WHO Histological Classification of Thymoma Satoshi Sonobe, MD, 1 Hideaki Miyamoto, MD, 1 Hiroshi Izumi, MD, 2 Bunsei Nobukawa, MD, 2 Toshiro Futagawa, MD, 1
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationPerigastric lymph node metastases in gastric cancer: comparison of different staging systems
Gastric Cancer (1999) 2: 201 205 Original article 1999 by International and Japanese Gastric Cancer Associations Perigastric lymph node metastases in gastric cancer: comparison of different staging systems
More informationSmall-cell lung cancer (SCLC) represents approximately
Original Article Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn G. Hancock, BS, Daniel J. Boffa, MD,
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationCharacteristics of intramural metastasis in gastric cancer. Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu
ORIGINAL ARTICLE Characteristics of intramural metastasis in gastric cancer Tatsuya Hashimoto Kuniyoshi Arai Yuichi Yamashita Yoshiaki Iwasaki Tsunekazu Hishima Author for correspondence: T. Hashimoto
More informationSurgery remains the mainstay treatment for localized
Surgical Results in T2N0M0 Nonsmall Cell Lung Cancer Patients With Large Tumors 5 cm or Greater in Diameter: What Regulates Outcome? Yasuhiko Ohta, MD, Ryuichi Waseda, MD, Hiroshi Minato, MD, Naoki Endo,
More informationPrognostic stratification of thymic epithelial tumors based on both Masaoka-Koga stage and WHO classification systems
Original Article Prognostic stratification of thymic epithelial tumors based on both Masaoka-Koga stage and WHO classification systems Geun Dong Lee 1, Hyeong Ryul Kim 2, Se Hoon Choi 2, Yong-Hee Kim 2,
More informationLung cancer is a prevalent health problem worldwide. It is the leading cause
Prognostic factors in resected stage I non small cell lung cancer with a diameter of 3 cm or less: Visceral pleural invasion did not influence overall and disease-free survival Jung-Jyh Hung, MD, a,b Chien-Ying
More informationPrognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer
Jpn. J. Clin. Oncol. 198, 1 (), 7-1 Prognostic Significance of Extranodal Cancer Invasion of Mediastinal Lymph Nodes in Lung Cancer KEIICHI SUEMASU, M.D. AND TSUGUO NARUKE, M.D. Department of Surgery,
More informationPrognostic Role of Gastrectomy in Patients With Gastric Cancer With Positive Peritoneal Cytology
Int Surg 2014;99:830 834 DOI: 10.9738/INTSURG-D-14-00119.1 Prognostic Role of Gastrectomy in Patients With Gastric Cancer With Positive Peritoneal Cytology Okihide Suzuki, Minoru Fukuchi, Erito Mochiki,
More informationPrognostic Factors in Resected Satellite Nodule T4 Non-Small Cell Lung Cancer
Prognostic Factors in Resected Satellite Nodule T4 Non-Small Cell Lung Cancer Jagan Rao, FRCS(C-Th), Rana A. Sayeed, FRCS(C-Th), Sandra Tomaszek, Stefan Fischer, MD, Shaf Keshavjee, MD, FRCSC, and Gail
More informationMOLECULAR AND CLINICAL ONCOLOGY 1: , 2013
MOLECULAR AND CLINICAL ONCOLOGY 1: 437-443, 2013 Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma
More informationClinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05
Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan
More informationNumber of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival
Number of Metastatic Lymph Nodes in Resected Non Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD, Dae Joon Kim, MD, Seong Yong Park, MD, Kil Dong Kim,
More informationAn Update: Lung Cancer
An Update: Lung Cancer Andy Barlow Consultant in Respiratory Medicine Lead Clinician for Lung Cancer (West Herts Hospitals NHS Trust) Lead for EBUS-Harefield Hospital (RB&HFT) Summary Lung cancer epidemiology
More informationSurgical treatment of thymoma: an 11-year experience with 761 patients
European Journal of Cardio-Thoracic Surgery 49 (2016) 1144 1149 doi:10.1093/ejcts/ezv288 Advance Access publication 30 August 2015 ORIGINAL ARTICLE Cite this article as: Zhao Y, Shi J, Fan L, Hu D, Yang
More informationTakaomi Hanaoka 1*, Makoto Kurai 1, Mitsuyo Okada 2, Satoshi Ishizone 3, Fumitoshi Karasawa 3, Akira Iizuka 3, Meguru Ikeyama 4 and Jun Nakayama 4
Hanaoka et al. Surgical Case Reports (2018) 4:2 DOI 10.1186/s40792-017-0413-0 CASE REPORT Open Access Pulmonary adenocarcinoma possibly developed from the cut-end of small-sized adenocarcinoma in the lung
More informationClinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer
Clinicopathological Characteristics and Outcome Indicators of Stage II Gastric Cancer According to the Japanese Classification of Gastric Cancer HITOSHI OJIMA 1, KEN-ICHIRO ARAKI 1, TOSHIHIDE KATO 1, KAORI
More informationPredictive risk factors for lymph node metastasis in patients with resected nonsmall cell lung cancer: a case control study
Moulla et al. Journal of Cardiothoracic Surgery (2019) 14:11 https://doi.org/10.1186/s13019-019-0831-0 RESEARCH ARTICLE Open Access Predictive risk factors for lymph node metastasis in patients with resected
More information